Stockhub

Petlife Pharmaceuticals, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 September 2022

  • curprev 19:2719:27, 23 September 2022 95.149.241.133 talk 713 bytes +713 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company's principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concentrated intravenous and injec..."
Retrieved from "https://stockhub.co/research/Petlife_Pharmaceuticals,_Inc."